Nonmotor outcomes in Parkinson’s disease: is deep brain stimulation better than dopamine replacement therapy?
Nonmotor symptoms are an integral part of Parkinson’s disease and cause significant morbidity. Pharmacological therapy helps alleviate the disease but produces nonmotor manifestations. While deep brain stimulation (DBS) has emerged as the treatment of choice for motor dysfunction, the effect on nonm...
Main Authors: | Rupam Borgohain, Rukmini Mridula Kandadai, Afshan Jabeen, Meena A. Kannikannan |
---|---|
Format: | Article |
Language: | English |
Published: |
SAGE Publishing
2012-01-01
|
Series: | Therapeutic Advances in Neurological Disorders |
Online Access: | https://doi.org/10.1177/1756285611423412 |
Similar Items
-
Guidelines for the use of botulinum toxin in movement disorders and spasticity
by: Jabeen Afshan, et al.
Published: (2011-01-01) -
Functional outcome of bilateral subthalamic nucleus-deep brain stimulation in advanced parkinson's disease patients: A prospective study
by: Swetha Tandra, et al.
Published: (2020-01-01) -
The effect of dual tasking and deep brain stimulation frequency parameters on gait in advanced Parkinson's disease
by: Swetha Tandra, et al.
Published: (2020-01-01) -
Dopamine-Induced Nonmotor Symptoms of Parkinson's Disease
by: Ariane Park, et al.
Published: (2011-01-01) -
Cryptoccocal menigitis as a primary manifestation in a patient with intestinal lymphangictasia
by: Shaik Afshan Jabeen, et al.
Published: (2012-01-01)